Realview Imaging

RealView Imaging provides interactive 3D holographic display solutions for medical imaging applications, using proprietary Digital Light Shaping technology to create accurate, threeD holograms floating in air that physicians can interact with through touch and manipulation. The HOLOSCOPE-i system has FDA clearance for use in interventional cardiology procedures including cardiac electrophysiology, structural heart disease interventions, interventional radiology, and complex surgical procedures. The holograms enable real-time visualization of patient anatomy during procedures, enhancing spatial understanding, procedural planning accuracy, and clinical outcomes without requiring physicians to look away from screens or The technology has been adopted by Philips for integration into imaging systems, and clinical workflows. with the first-in-human clinical trials completed evaluating live 3D holographic imaging. Founded in 2008 and headquartered in Yokneam Illit, Israel, the company has raised approximately $25.0M in Series C funding from investors including OurCrowd, Kyocera Ventures, and Medtronic.